David X. Zhao

A Comprehensive Appraisal of Risk Prediction Models for Cardiogenic Shock.

D. Holmes, A. Truesdell, W. Nicholson, 2022, Shock.

Chronic Ca2+/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart Failure

D. Kitzman, D. Herrington, M. Callahan, 2021, The Journal of Pharmacology and Experimental Therapeutics.

Role of adjunct anticoagulant or thrombolytic therapy in cardiac arrest without ST-segment-elevation or percutaneous coronary intervention: A systematic review and meta-analysis.

A. Truesdell, S. T. Rab, S. Vallabhajosyula, 2022, The American journal of emergency medicine.

Concomitant Sepsis Diagnoses in Acute Myocardial Infarction-Cardiogenic Shock: 15-Year National Temporal Trends, Management, and Outcomes

P. Lawler, S. van Diepen, P. E. Miller, 2022, Critical care explorations.

Efficacy and safety of angiotensin II in cardiogenic shock: A systematic review.

S. Vallabhajosyula, P. M. Belford, P. Wieruszewski, 2023, The American journal of emergency medicine.

Abstract 044: Association Of Cardiovascular Comorbidities With Sars-cov-2 Seropositivity In A Population-based Cohort.

A. Correa, D. Herrington, W. Weintraub, 2021 .

TRIO Risk Score: Simple, Yet Complex.

S. Vallabhajosyula, David X. Zhao, Akshay Machanahalli Balakrishna, 2022, Mayo Clinic proceedings.

Society of Cardiovascular Angiography and intervention Stage-B cardiogenic shock: An interventional-heart failure-critical care conundrum

S. Vallabhajosyula, P. M. Belford, David X. Zhao, 2023, IHJ Cardiovascular Case Reports (CVCR).

Escalation strategies, management, and outcomes of acute myocardial infarction‐cardiogenic shock patients receiving percutaneous left ventricular support

R. Applegate, S. Vallabhajosyula, J. Jentzer, 2023, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.